Omission of Axillary Lymph Node Dissection in Early-Stage Breast Cancer With Limited Sentinel Lymph Node Metastasis: A Propensity Score-Matched Analysis
Clinical Breast Cancer · 2026
DOI: 10.1016/j.clbc.2025.12.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Breast Cancer, 2026. Verfasst von Changzai Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China; Hebei Key Laboratory of Breast Cancer Molec…. Hauptthemen laut MEDLINE: Breast Neoplasms, Lymph Node Excision, Sentinel Lymph Node, Neoplasm Recurrence, Local. Die Arbeit nennt 34 Literaturangaben. Gefördert von: Hebei Provincial Department of Science and Technology.
Abstract (Originalsprache)
BACKGROUND: Whether axillary lymph node dissection (ALND) can be safely omitted clinically node-negative (cN0) breast cancer with limited sentinel lymph (SLN) metastasis remains uncertain, particularly after mastectomy. METHODS: This retrospective cohort included women with T1-T2 cN0 breast cancer and positive SLN between 2015 and 2020. Patents underwent sentinel lymph node biopsy (SLNB) alone or ALND. Propensity score matching (1:1, nearest neighbor, caliper 0.02 on logit) balanced age, T stage, tumor grade, vascular invasion, number of positive SLNs, ER/PR/HER2, Ki-67, surgery type, chemotherapy, and radiotherapy. Kaplan-Meier and Cox regression estimated overall survival (OS) recurrence-free survival (RFS). RESULTS: Of 1244 patients screened, 1038 were analyzed (577 ALND, 461 SLNB alone; median follow-up 68 months), After matching (283 pairs), 5-year OS was 97.1% (95% CI, 95.0-99.3) for ALND and 96.1% (93.8-98.5) for SLNB alone. Five-year RFS was 96.8% (94.7-99.0) versus 97.0% (94.9-99.0). No statistically significant difference was found in OS (HR, 1.14, 95% CI, 0.51-2.54, P = .75) and RFS (HR, 0.86, 95% CI, 0.36-2.05, P = .74) between the ALND and SLNB alone. Findings were consistent among patients with 1 to 3 positive SLNs, regardless of surgery type. All 22 patients with 4 to 6 positive SLNs underwent ALND, precluding comparison. CONCLUSION: In cN0 breast cancer patients with 1 to 3 positive SLNs, omitting ALND did not compromise OS or RFS after mastectomy or breast-conserving surgery. These results support broader application of de-escalated axillary surgery while prospective validation for higher nodal burden remains necessary.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Breast Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China; Hebei Key Laboratory of Breast Cancer Molecular Medicine, The Fourth Hospital of Hebei Medical University, Shijia…
- College of Nursing and Rehabilitation, North China University of Science and Technology, Tangshan, Hebei, China.
Förderung
- Hebei Provincial Department of Science and Technology
Zitieren
APA
Li, C., Zhang, P., Wang, J., & Geng, C. (2026). Omission of Axillary Lymph Node Dissection in Early-Stage Breast Cancer With Limited Sentinel Lymph Node Metastasis: A Propensity Score-Matched Analysis. Clinical Breast Cancer. https://doi.org/10.1016/j.clbc.2025.12.006
Vancouver
Li C, Zhang P, Wang J, Geng C. Omission of Axillary Lymph Node Dissection in Early-Stage Breast Cancer With Limited Sentinel Lymph Node Metastasis: A Propensity Score-Matched Analysis. Clinical Breast Cancer. 2026. doi:10.1016/j.clbc.2025.12.006
BibTeX
@article{Li2026,
author = {Li, Changzai and Zhang, Pan and Wang, Jiaxing and Geng, Cuizhi},
title = {Omission of Axillary Lymph Node Dissection in Early-Stage Breast Cancer With Limited Sentinel Lymph Node Metastasis: A Propensity Score-Matched Analysis},
journal = {Clinical Breast Cancer},
year = {2026},
doi = {10.1016/j.clbc.2025.12.006}
}
EUVIMED